https://doi.org/10.5281/zenodo.11154992
Mediterr J Pharm Pharm Sci, vol.4 n2, 15-22, June, 2024, Publication date May 08, 2024 Clinical profile of Libyan patients admitted with diabetic ketoacidosis Aya M.O. Alfoghi, Salsabel A. Keshlaf, Samia A.A. Elmiladi Blood pressure, diabetes ketoacidosis, diabetes mellitus, high dependent unit, plasma glucose

Original article

https://doi.org/10.5281/zenodo.11173840
Mediterr J Pharm Pharm Sci, vol.4 n2, 23-29, June, 2024, Publication date May 10, 2024 Effects of jatropha curcas root extracts on the metabolic profile of mature female rats Ale Ayotunde Oladunni, Odesanmi Omolola Selina, Magbagbeola Olubunmi Abiola J. curcas, metabolic effects, hyperlipidemia, hyperglycemia

Original article

https://doi.org/10.5281/zenodo.11391834
Mediterr J Pharm Pharm Sci, vol.4 n2, 37-46, June, 2024, Publication date May 29, 2024 Knowledge, attitude and practice of patient referral among patent and proprietary medicine vendors in Obio-Akpor, Rivers State, Nigeria Igboamalu Chukwunonso, Daprim Samuel Ogaji Attitude, barriers, facilitators, knowledge, patent medicine vendor, practice, referral

Original article

https://doi.org/10.5281/zenodo.11479336
Mediterr J Pharm Pharm Sci, vol.4 n2, 55-63, June, 2024, Publication date June 04, 2024 Knowledge, performance, and awareness towards the use of disinfectant and hand sanitizers during COVID-19 pandemic: A questionnaire-based survey Fayza R. Neser, Fatima A. Ibsheesh, Alaa M. Alhaj, Khaula A. Alghazal, Kawther M. Ibrahem, Osama M. Bouder Awareness, disinfectant use, hand sanitizer composition, health risks, Libya 

Original article

https://doi.org/10.5281/zenodo.10946622
Mediterr J Pharm Pharm Sci, vol.4 n2, 1-8, June, 2024, Publication date April 08, 2024 The seroprevalence of IgM and IgG antibodies production among expected COVID-19 patients: A retrospective cohort study Ibrahim M. Al-osta, Melaad A. Aldhduh, Marwa S. Al-anour, Hameda M. Masoud, Mona S. Al-alous, Bushra O. Albassari COVID-19, IgG, IgM, Libya, SARS-CoV-2

Original article

https://doi.org/10.5281/zenodo.11224367
Mediterr J Pharm Pharm Sci, vol.4 n2, 30-36, June, 2024, Publication date May 22, 2024 Breast cancer delay presentation among Libyan patients: Demographic and clinical features Aisha A. El Ashouri, Mohamed N. M. Smeo, Laila T. Sabei, Hamida A. Aldwebi, Nadia M. AbuBaker, Malak S. Abu-Khatwa, Qabs F. Madi Breast cancer, clinical stage, help-seeking behavior, patient delay

Original article

https://doi.org/10.5281/zenodo.11477048
Mediterr J Pharm Pharm Sci, vol.4 n2, 47-54, June, 2024, Publication date June 04, 2024 The impact of tablet shape on quality control parameters for metronidazole tablet marketed in Libya Wedad M. Saleh, Azah M. Ali, Darine M. Abozaid Hardness test, metronidazole, pharmaceutical analysis, shape 

Short communication

Highlight https://doi.org/10.5281/zenodo.12171291
Mediterr J Pharm Pharm Sci, vol.4 n2, 64-68, June, 2024, Publication date June 19, 2024 Body mass index and vitamin D in Libyan women Rehab R. Walli, Abed Alnaser A. Drbal, Masarra N. Altabib Age, BMI, lifestyle changes, obesity

Short communication

https://doi.org/10.5281/zenodo.12571620
Mediterr J Pharm Pharm Sci, vol.4 n2, 69-74, June, 2024, Publication date June 27, 2024 Effect of beverages on the disintegration time of drugs in the tablet dosage form Samia A. Majeed Bioavailability, disintegration, solid dosage form, OTC drugs

Short communication

https://doi.org/10.5281/zenodo.11111150
Mediterr J Pharm Pharm Sci, vol.4 n2, 9-14, June, 2024, Publication date May 03, 2024 Community response to genetically modified food product in Libya  Aymen A. Mohammed, Ahmed A. Ali, Sabri D. Mohammed, Younis Alkarghli Biotechnology, genetically modified product, food 

Short communication

https://doi.org/10.5281/zenodo.12601827
Mediterr J Pharm Pharm Sci, vol.4 n2, 75-81, June, 2024, Publication date June 30, 2024 Determination of the structural parameters of Repaglinide in tablet: an antidiabetic drug, using Spectroscopic methods Djawhara Haddad, Nasser Belboukhari, Khaled Sekkoum, Meriem Bouanini Repaglinide, FT-IR, NMR-1H, UV

Short communication